Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Yayoi Nakayama"'
Publikováno v:
Expert Opinion on Drug Safety. :1-14
Sodium-glucose co-transporter-2 (SGLT2) inhibitors such as empagliflozin are increasingly prescribed as initial glucose-lowering drugs for type 2 diabetes (T2D), based on their cardiorenal benefits. However, information regarding the safety and the e